summary: The authors investigated the side effects of mitoxantrone, a chemotherapy drug used to treat aggressive MS, in women. They found that whilst it may affect fertility, this risk is reduced if hormones are used during the treatment.

authors: Cocco E, Sardu C, Gallo P, Capra R, Amato MP, Trojano M, Uccelli A, Marrosu MG; the FEMIMS group

source: Mult Scler. 2008 Aug 13. [Epub ahead of print]

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: